tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ALKS Stock Latest News

Alkermes initiates Phase 2 study evaluating ALKS 2680 in idopathic hypersomnia
The FlyAlkermes initiates Phase 2 study evaluating ALKS 2680 in idopathic hypersomnia
9h ago
ALKS
Alkermes price target raised to $52 from $40 at Deutsche Bank
PremiumThe Fly
Alkermes price target raised to $52 from $40 at Deutsche Bank
5d ago
ALKS
Alkermes price target raised to $35 from $34 at BofA
PremiumThe Fly
Alkermes price target raised to $35 from $34 at BofA
13d ago
ALKS
Alkermes initiated with a Sector Perform at RBC Capital
PremiumThe Fly
Alkermes initiated with a Sector Perform at RBC Capital
19d ago
ALKS
Alkermes upgraded to Neutral from Sell at UBS
PremiumThe Fly
Alkermes upgraded to Neutral from Sell at UBS
28d ago
ALKS
Alkermes: Hold Rating Amid Declining Base Business Value and Optimistic Orexin Outlook
PremiumRatingsAlkermes: Hold Rating Amid Declining Base Business Value and Optimistic Orexin Outlook
2M ago
ALKS
Regulatory Challenges Pose Significant Risks to Alkermes’ Financial Stability
Premium
Company Announcements
Regulatory Challenges Pose Significant Risks to Alkermes’ Financial Stability
2M ago
ALKS
Alkermes plc Reports Record Revenues in 2024 Earnings Call
Premium
Company Announcements
Alkermes plc Reports Record Revenues in 2024 Earnings Call
2M ago
ALKS
Alkermes price target raised to $32 from $30 at Goldman Sachs
PremiumThe Fly
Alkermes price target raised to $32 from $30 at Goldman Sachs
2M ago
ALKS
Alkermes outlook reflects underlying strength, says H.C. Wainwright
PremiumThe Fly
Alkermes outlook reflects underlying strength, says H.C. Wainwright
2M ago
ALKS
Alkermes price target raised to $38 from $35 at TD Cowen
PremiumThe Fly
Alkermes price target raised to $38 from $35 at TD Cowen
2M ago
ALKS
Alkermes price target raised to $34 from $33 at BofA
PremiumThe Fly
Alkermes price target raised to $34 from $33 at BofA
2M ago
ALKS
Alkermes: Stability with Limited Upside Amid Program Expectations and Competitive Pressures
PremiumRatingsAlkermes: Stability with Limited Upside Amid Program Expectations and Competitive Pressures
2M ago
ALKS
Alkermes plc Reports Strong 2024 Financial Results
Premium
Company Announcements
Alkermes plc Reports Strong 2024 Financial Results
2M ago
ALKS
Alkermes’ Strong Financial Performance and Future Growth Prospects Drive Buy Rating
Premium
Ratings
Alkermes’ Strong Financial Performance and Future Growth Prospects Drive Buy Rating
2M ago
ALKS
Alkermes sees FY25 revenue $1.340B-$1.430B, consensus $1.41B
PremiumThe Fly
Alkermes sees FY25 revenue $1.340B-$1.430B, consensus $1.41B
2M ago
ALKS
Alkermes reports Q4 non-GAAP EPS $1.05, consensus 76c
PremiumThe Fly
Alkermes reports Q4 non-GAAP EPS $1.05, consensus 76c
2M ago
ALKS
Alkermes initiated with a Buy at Deutsche Bank
PremiumThe Fly
Alkermes initiated with a Buy at Deutsche Bank
2M ago
ALKS
ALKS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ALKS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
ALKS
Alkermes price target raised to $33 from $31 at BofA
PremiumThe FlyAlkermes price target raised to $33 from $31 at BofA
2M ago
ALKS
Alkermes Advances Orexin Program with ALKS 2680 Candidate
Premium
Company Announcements
Alkermes Advances Orexin Program with ALKS 2680 Candidate
3M ago
8K
ALKS
Alkermes Prepares for New Flexibility Post Credit Termination
Premium
Company Announcements
Alkermes Prepares for New Flexibility Post Credit Termination
3M ago
8K
ALKS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >